Sermonix Pharmaceuticals LLC, a privately held biopharmaceutical firm developing cutting-edge therapeutics for the treatment of metastatic breast cancers (mBC), announced that China's National Medical Products Administration (NMPA) has approved...
During the BIO International Convention 2024 in San Diego, USA, the Department of Health – Abu Dhabi (DoH), the healthcare industry's regulator, and MSD, a top biopharmaceutical company, signed a Memorandum of Understanding (MoU). DoH and MSD...
Halozyme Therapeutics, Inc, a biopharmaceutical firm, recently made the announcement that it had been granted European Patent No. 4269578. This patent covers the Enhanze rHuPH20 product that is made using Halozyme's Enhanze manufacturing methods...
Opus Genetics, a patient-first, clinical-stage gene therapy company developing treatments for inherited retinal diseases, and the Department of Health – Abu Dhabi (DoH), the Emirate's regulator of the healthcare sector, signed a Memorandum of...
Amplitude Vascular Systems (AVS), a medical device company focused on the safe and effective treatment of severely calcified arterial disease, declared that it has received an investigational device exemption (IDE) from the United States Food and...
Orchid Pharma has secured Drugs Controller General of India (DCGI) endorsement for the manufacturing and promoting of its invented New Chemical Entity active pharmaceutical ingredient (API), enmetazobactam.DCGI has conceded consent to produce and...
Annogen, a biotechnology firm declared a research collaboration with Orchard Therapeutics, a worldwide gene therapy treatment pioneer, for the recognizable proof of immune cell-explicit human advertisers for use in specific pre-clinical...
Torrent Pharmaceuticals announced that it has signed a non-exclusive patent licensing arrangement with Takeda to commercialize Vonoprazan in India. Vonoprozan is a new potassium-competitive acid blocker (P-CAB) that treats acid-related illnesses...
UNION Therapeutics A/S (Association), a clinical stage and drug improvement organization focused on immunology, reports effective culmination of the ADESOS stage 2b, randomized, dose finding study assessing orismilast as an oral treatment in 233...
During the BIO 2024 International Convention, the Department of Health – Abu Dhabi (DoH), the Emirate's healthcare regulator, entered into a Memorandum of Understanding (MoU) with Pfizer Gulf FZ LLC, a global pharmaceutical firm...
, CDSCO.jpg)
.jpg)